Scientific Program
08:00-17:00
Registration
08:50-09:00
Welcome and Opening of the Congress
Irit Avivi, Tel Aviv Sourasky Medical Center, Israel
09:00-10:30
Session 1: Diffuse Large Cell Lymphoma
09:00-09:25
Where We Are in DLBCL Management in 2019
Marek Trneny
Charles University, Czech Republic
09:25-09:50
Treatment of DLBCL at Relapse (Excluding CAR T Cell Therapy)
Christian Gisselbrecht
Hôpital Saint-Louis, France
09:50-10:15
Treatment at NHL During Pregnancy
Irit Avivi
Tel Aviv Institute of Hematology and Bone Marrow Transplantation, Tel Aviv Medical Center, Israel & Sackler School of Medicine, Tel Aviv University
10:15-10:30
Discussion
10:30-11:00
Coffee Break, Networking and visit the Exhibition
11:00-12:30
Session 2: Follicular Lymphoma
11:00-11:25
Treatment at Diagnosis
11:25-11:50
Management at Diagnosis
Igor Aurer
University Hospital Centre Zagreb, Croatia
11:50-12:15
Management at Relapse
12:15-12:30
Discussion
12:30-13:30
Lunch Break, Networking and visit the Exhibition
13:30-15:00
Session 3: Lymphoma Survivorship
13:30-13:55
Physician Perspective
Dana Barnea
Memorial Sloan Kettering Cancer Center, USA
13:55-14:20
Long Term Complications
14:20-14:45
Patient Perspective
14:45-15:00
Discussion
15:00-15:30
Coffee Break, Networking and visit the Exhibition
15:30-16:30
Session 4: Peripheral T Cell Lymphoma
15:30-15:55
Transplantation in Peripheral T Cell Lymphoma
Norbert Schmitz
Medizinicum, Germany
15:55-16:20
Treatment of Peripheral T Cell Lymphomas
Ronit Gurion
Rabin Medical Center, Israel
16:20-16:30
Discussion
16:30-17:00
Oral Presentations
Chairperson: Irit Avivi, Tel Aviv Sourasky Medical Center, Israel
09:00-10:30
Session 5: Hodgkin Lymphoma
09:00-09:25
Treatment of Newly Diagnosed HL Patients
09:25-09:50
Treatment at Relapse
Anna Sureda
Catalan Institute of Oncology, Spain
09:50-10:15
PET Scan in HL
Eva Domingo
Catalan Institute of Oncology, Spain
10:15-10:30
Discussion
10:30-11:00
Coffee Break, Networking and visit the Exhibition
11:00-12:30
Session 6: Rare Lymphomas
11:00-11:25
Update on Hairy Cell Leukemia: From Diagnosis to Treatment
Tamar Tadmor
Bnei-Zion Medical Center, Israel
11:25-11:50
Lymphomas in Immunocompromised Patients
11:50-12:15
CLL - Chemo Free Era
Yair Herishano
Tel Aviv Sourasky Medical Center, Israel
12:15-12:30
Discussion
12:30-13:30
Lunch Break, Networking and visit the Exhibition
13:30-15:00
Session 7: Immunotherapy Focusing on CAR T Cell Therapy
13:30-13:55
ZUMA 1 – Updates
13:55-14:20
The Future of CAR T Cells
14:20-14:45
CAR T Cell - Future Perspectives
14:45-15:00
Discussion
15:00-15:30
Coffee Break, Networking and visit the Exhibition
15:30-16:30
Session 8: Extra Nodal Lymphomas
15:30-15:55
PCNSL - Current Diagnostic and Therapeutic Algorithm
Andrés Ferreri
IRCCS San Raffaele Scientific Institute, Italy
15:55-16:20
MALT Lymphoma – What's New?
Annarita Conconi
Azienda Sanitaria Locale di Biella, Italy
16:20-16:30
Discussion